GRAIL
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
1525 O Brien Dr, Menlo Park, California,...Phone Number
(833) 464-7245Website
www.grail.comRevenue
$156.1 MillionStock Symbol
GRALIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
4
1
6
2
2
About GRAIL
GRAIL is a healthcare company dedicated to early cancer detection through innovative technologies, notably their Galleri test, which allows for multi-cancer early detection (MCED) by analyzing DNA in the bloodstream. The company aims to transform cancer screening and reduce mortality rates associated with cancer by utilizing advanced methylation analysis and machine-learning algorithms. Their intended clients include healthcare providers, oncologists, and individuals seeking proactive cancer screening solutions. GRAIL's mission focuses on changing the trajectory of cancer mortality by bringing together various stakeholders to adopt effective cancer detection technologies.Explore more
GRAIL Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GRAIL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once GRAIL has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at GRAIL
Product Launch: Get notified when GRAIL launches new products
GRAIL, which may be a good buyer, showed buying intent in Masked Content Topic
Check if GRAIL has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if GRAIL is spiking on competitors!
Click to see if GRAIL had a recent Job posting/layoffs
Earning: See what the market has to say on GRAIL recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined GRAIL as Masked Content
Find 3 more new buyers
Compare Similar Companies to GRAIL
Compare insights from companies similar to GRAIL, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GRAIL is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GRAIL is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GRAIL.
GRAIL financials insights
Gather financial insights about GRAIL, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$100M
2017
Series B
$900M
2018
Series C
$300M
2019
Unspecified
$125M
2020
Series D
$390M
2025
Stock/Share Issuance
$325M
GRAIL Tech Stack
A closer look at the technologies used by GRAIL
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Promotion
Executive Move
Executive Moves, Promotion
Hiring Plans
GRAIL has more open roles in Operations than it has had at any time in the past 6 months.
Hiring Plans
Person-Based
Customer Service, Doctors / Physicians, Public Health
Project
Laboratory Operations, Medical Research, Clinical Operations
GRAIL News & Media
Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Grail (GRAL) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 8/4/2026GRAIL, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 4, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
GRAIL Shareholders Between May 13, 2025 and February 19, 2026 - Contact Bernstein Liebhard For More Information Regarding Lawsuit$GRAL Fraud Notice: GRAIL, Inc. Accused of Securities Fraud over Trial Results in Filed Class Action Lawsuit – Investors Notified to Contact BFA Law
GRAIL, Inc. Accused of Securities Fraud over Trial Results in Filed Class Action Lawsuit – Investors Notified to Contact BFA LawGRAL DEADLINE: The Gross Law Firm Reminds GRAIL, Inc. Investors of Upcoming Securities Class Action Deadline
NEW YORK, June 16, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GRAIL, Inc. (NASDAQ: GRAL). Shareholders who purchased shares of GRAL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GRAIL
Sign Up For FreeTo access detailed company insights
GRAIL is a healthcare company dedicated to early cancer detection through innovative technologies, notably their Galleri test, which allows for multi-cancer early detection (MCED) by analyzing DNA in the bloodstream. The company aims to transform cancer screening and reduce mortality rates associated with cancer by utilizing advanced methylation an... Read More
